Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 10.28
- Piotroski Score 2.00
- Grade N/A
- Symbol (TELO)
- Company Telomir Pharmaceuticals, Inc. Common Stock
- Price $4.22
- Changes Percentage (-5.58%)
- Change -$0.25
- Day Low $4.11
- Day High $4.90
- Year High $20.72
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. It develops TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic intervention against age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, as well as for post-chemotherapy recovery by interrupting and preventing the interleukin-17 induced inflammatory pathways. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. on October 10, 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Baltimore, Maryland.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/12/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio N/A
- Forward P/E Ratio N/A
- P/E Growth N/A
- Net Income $-13,071,864
Income Statement
Quarterly
Annual
Latest News of TELO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
TELO Stock Price | Telomir Pharmaceuticals Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
Telomir Pharmaceuticals is a pre-clinical-stage company focusing on developing TELOMIR-1, a small molecule for oral in situ therapeutic treatment for human stem cells....
By MarketWatch | 2 days ago -
Telomir Pharma Shares Rise 4% After Anti-Aging Drug News
Telomir Pharmaceuticals saw a rise in after-hours trading after announcing positive results for its Telmor-1 anti-aging treatment. Shares were up 4.7% at $4.40....
By MarketWatch | 2 days ago -
"Pillowcase Rapist" will move to LA's Antelope Valley despite community objections
Despite objections, convicted serial rapist Christopher Hubbart, known as the "Pillowcase Rapist," can relocate to Antelope Valley in Los Angeles County. Judge's order allows his conditional release t...
By CBS News | 1 month ago
